Brooks, Nathan A.

Eli Lilly (United States) · Eli Lilly (Spain)

1 paper on CoChatORCID 0009-0007-6028-2096

Most cited papers

Verified
Characterization of LY2228820 dimesylate, a potent and selective inhibitor of p38 MAPK with antitumor activity
Campbell, R. M., Anderson, B. D., Brooks, N. A., Brooks, H. B., Chan, E. M., De Dios, A., Gilmour, R., Graff, J. R., Jambrina, E., Mader, M., et al. (2014) · Molecular Cancer Therapeutics
Melanoma and MAPK PathwaysProtein Kinase Regulation and GTPase Signaling
Cited by 121

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free